Workflow
Takeda Pharmaceutical Company (TAK) Signs a Research Partnership with Nabla Bio

​Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 14, Reuters reported that Takeda Pharmaceutical Company Limited (NYSE:TAK) and US biotechnology company Nabla Bio signed a major research partnership. The partnership is focused on deepening the use of AI to accelerate drug delivery. ​This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this partnership, Nabla will use it ...